BPC-157 + TB-500 — 20 mg

Combination of BPC-157 (pentadecapeptide) and TB-500 (thymosin β4 fragment). 10 mg + 10 mg. Preclinical evidence base. A two-peptide combination studied in preclinical tissue-repair models for angiogenesis, cell migration, and cytoprotection. Research focus: Angiogenesis, Tissue-Repair Signaling, Actin Dynamics, Cytoprotection. Documented research areas: Tissue repair, Cell migration, Cytoprotection. Research Use Only — not for human or veterinary consumption. Supplied as a reference material for in-vitro and in-vivo laboratory research; not evaluated by the FDA and not intended to diagnose, treat, cure, or prevent any disease.